高血脂肠道菌群数据

肠道菌群在脂肪代谢调控中扮演着举足轻重的角色。本产品整合了高血脂患者的肠道菌群数据，不仅有助于深入理解高血脂的发病机制，更为高血脂的精准治疗研究开辟了新路径，有效降低心脑血管疾病的风险。此外，本产品也可用于心脑血管疾病风险评估模型研究，推进诊断试剂和药物的开发，为高血脂及其相关慢性病的综合管理提供全面的支持。

Gut microbiota plays a pivotal role in the regulation of lipid metabolism. This dataset integrates gut microbiota data from patients with hyperlipidemia. It not only facilitates in-depth understanding of the pathogenesis of hyperlipidemia, but also opens up new avenues for precision therapy research on hyperlipidemia, effectively reducing the risk of cardiovascular and cerebrovascular diseases. Furthermore, this dataset can be used for research on cardiovascular and cerebrovascular disease risk assessment models, promotes the development of diagnostic reagents and drugs, and provides comprehensive support for the comprehensive management of hyperlipidemia and its related chronic diseases.

搜集汇总

背景与挑战

背景概述

该数据集整合了全国范围内高血脂患者的肠道菌群数据，主要用于高血脂发病机制研究、精准治疗及心脑血管疾病风险评估。数据集由上海芯超医学检验所提供，属于生物医药专区试验测试，每年更新一次，存储大小为610MB。